Welcome to LookChem.com Sign In|Join Free
  • or
Triumph International Development LimiltedWZ4002//file1.lookchem.com/300w/synthetic/2022-01-23-03/7120c1b0-57ce-4e86-bd39-6b7b1ce5f7a1.png
qq

Communicate with Supplier:

Mr. Steven Li
Mr. Steven Li: What can I do for you?

WZ4002 CAS NO.1213269-23-8

Min.Order Quantity:
100 Metric Ton
Purity:
98%min
Port:
Qingdao,China
Payment Terms:
L/C,T/T,MoneyGram,Other

Add to Inquiry Cart

Product Details

Keywords

  • 1213269-23-8
  • Sell high quality WZ4002 produced in China factory
  • WZ4002 seller in China

Quick Details

  • ProName: WZ4002
  • CasNo: 1213269-23-8
  • Molecular Formula: C25H27ClN6O3
  • Appearance: white powder
  • Application: Used for research and industrial manuf...
  • DeliveryTime: Within7-10 days after receipt of your ...
  • PackAge: As customer request
  • Port: Qingdao,China
  • ProductionCapacity: 100kg/Month Metric Ton/Day
  • Purity: 98%min
  • Storage: Store in a cool,dry place and keep awa...
  • Transportation: Common products:Sea/Air/Courier Dange...
  • LimitNum: 100 Metric Ton

Superiority

triumph chemical title

triumph company office picture

triumph company advantage

triumph testing title picture

triumph testing way

welcome to contact us

lorcaserin(856681-05-5)is an orally administered agent and a selective 5-ht2c receptor agonist for the treatment of obesity. it had been approved for marketing in us by fda on 27 june in 2012. in clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.

Details

quick details

  • proname: 1213269-23-8 c25h27cln6o3 ...
  • casno: 1213269-23-8
  • molecular formula: c25h27cln6o3
  • appearance: white powder
  • application: a novel mutant-selective egfr kinase i...
  • deliverytime: 5-7 days after payment
  • package: woven bag

  • purity: 98%productioncapacity: 1 kilogram/day
  • storage: normal temperature
  • transportation: ocean shipping express delivery
  • limitnum: 100 gram

superiority

wz4002 basic information
in vitro studies in vivo studies
product name: wz4002
synonyms: wz4002;n-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide;n-[3-[[5-chloro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]oxy]phenyl]-2-propenamide;wz4002(hbr);n-{3-[(5-chloro-2-{[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino}-4-pyrimidinyl)oxy]phenyl}acrylamide;n-[3-[5-chloro-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;n-[3-[[5-chloro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]oxy]phenyl]-2-propenamide wz 4002;wz 4002 n-[3-[[5-chloro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]oxy]phenyl]-2-propenamide
cas: 1213269-23-8
mf: c25h27cln6o3
mw: 0
einecs: -0
product categories: wz4002 is an egfr t790m inhibitor(ic50<20nm).;inhibitors
mol file: mol file
wz4002 structure
wz4002 chemical properties
density 1.314
safety information
msds information
wz4002 usage and synthesis
biological activity wz4002 is a novel, mutant selective egfr inhibitor. the ic50 is 2 nm/8 nm when it acts on ic50 of 2 nm / 8 nm in egfr (l858r) / (t790m), and it has no inhibitory effect on erbb2 phosphorylation (t798i).
in vitro studies wz4002 also inhibit other egfr genotypes. for instance, the ic50 is 2nm and 6nm respectively when it acts on e746_a750 and e746_a750/t790m. besides, the ic50 is 32nm when it acts on wild-type egfr. it could inhibit the phosphorylation of egfr, akt and erk1/2 when it acts on non-small cell lung cancer (nsclc). wz4002 also could inhibit the phosphorylation of egfr when it acts on nih-3t3 cells expressing different egfrt790m mutant alleles. the dissociation constant of kinase was 95% higher when in the test when wz4002 involved than that in the test dmso involved instead. because in aniline substitution in the c2 wz4002 could obtain a methoxy group when it acts on egfr, thus it’s more effective when it acts on egfr than wz3146. compared with the quinazoline inhibitors, the efficiency of wz4002 is 100 times lower than when it acts on wild-type egfr. the inhibitory effect of wz4002 on egfr kinase activity of recombinant l858r / t790m protein is much higher than restrainable wild-type egfr’s. however hki-272 and gefitinib are happened to have opposite inhibitory effect compared with wz4002. in addition, phosphorylation of egfr in h1975 and hcc827 cells of anti-src tki could be completely inhibited by third-generation egfr tki and wz4002.
in vivo studies when treated with t790m mutant mouse model for 2 weeks and had been used to study the efficacy of wz4002, it is found that treatment with wz4002 resulted in more effective significant tumor regression compared to the control group. when treated with low dose wz4002 and high dose wz4002, it would resulted in a 26% and 36% decrease in average uptake respectively.
usage a novel mutant-selective egfr kinase inhibitor of egfrl858r and egfrl858r/t790m with ic50s of 2 nm and 8 nm, respectively.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)